 | • レポートコード：20QY06-00701 • 出版社/出版日：QYResearch / 2020年6月3日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、132ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、アルガトロバンのグローバル市場について種類別（アルガトロバンパウダー、アルガトロバン注射）、用途別（ヘパリン誘発性血小板減少症（HIT）、経皮的冠動脈インターベンション、脳動脈血栓症）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・アルガトロバン市場の概要 ・世界の主要地域別アルガトロバン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のアルガトロバン市場規模2015-2026：種類別（アルガトロバンパウダー、アルガトロバン注射） ・世界のアルガトロバン市場規模2015-2026：用途別（ヘパリン誘発性血小板減少症（HIT）、経皮的冠動脈インターベンション、脳動脈血栓症） ・アルガトロバンの北米市場規模2015-2020 ・アルガトロバンのヨーロッパ市場規模2015-2020 ・アルガトロバンの中国市場規模2015-2020 ・アルガトロバンの日本市場規模2015-2020 ・アルガトロバンの東南アジア市場規模2015-2020 ・アルガトロバンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Pfizer, Inc、SANDOZ、GlaxoSmithKline Plc、fresenius-kabi、Eagle Pharmaceuticals, Inc、Mitsubishi Tanabe Pharma、Teva Pharmaceutical Industries Ltd、WEST-WARD,INC） ・アルガトロバンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・アルガトロバンの市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Argatroban Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Argatroban market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5- [(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has 4 asymmetric carbons. One of the asymmetric carbons has an R configuration (stereoisomer Type I) and an S configuration (stereoisomer Type II). Argatroban consists of a mixture of R and S stereoisomers at a ratio of approximately 65:35.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Argatroban market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Argatroban industry.
Based on our recent survey, we have several different scenarios about the Argatroban YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 60 million in 2019. The market size of Argatroban will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Argatroban market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Argatroban market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Argatroban market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Argatroban market. The report also includes nautical information, where it shows Argatroban market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Argatroban market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Argatroban market.
In the last several years, global market of Argatroban Industry decreased with the average production growth rate about -15%. In 2015, global capacity of Argatroban reduced to 34786 grams
from 65183 grams since 2011. It is predicted that the argatroban demand will continue to decrease with a average growth rate of -9% in the coming five years.
Japan is the still largest supplier of argatroban with the production market share of 35% and the consumption market share of 22% in 2015.
The price of argatroban is relatively expensive. The largest consumers are developed countries with high income. USA occupied a market share of 34%. The second place is Europe, following North America with the consumption market share of 22% in 2015.
China has few companies entering the market with production share of only 8%, and demand cannot be satisfied with supply. Large quantities of argatroban have to be imported.
Intially, compared with hirudin and heparin, the therapeutic dose has little effect on platelet, no antigen and strong antithrombotic effect. The sale value has reached 190 million USA dollars in 2008. But because of its narrow therapeutic area, uncertain factors on human’s bodies and fierce competition from other substitutes, it sales far less than other thrombin inhibitor. The value reduced to 101 million USA dollars in 2015.
Geographical Analysis:
Based on region, the global Argatroban market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Argatroban market are
Pfizer, Inc
SANDOZ
GlaxoSmithKline Plc
fresenius-kabi
Eagle Pharmaceuticals, Inc
Mitsubishi Tanabe Pharma
Teva Pharmaceutical Industries Ltd
WEST-WARD,INC
Segment by Type
Argatroban Powder
Argatroban Injection
Segment by Application
Heparin-induced thrombocytopenia (HIT)
Percutaneous Coronary Intervention
Cerebral arterial thrombosis
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Argatroban market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Argatroban market.
• The market share of the global Argatroban market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Argatroban market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Argatroban market.
1 Argatroban Market Overview
1.1 Argatroban Product Scope
1.2 Argatroban Segment by Type
1.2.1 Global Argatroban Sales by Type (2020-2026)
1.2.2 Argatroban Powder
1.2.3 Argatroban Injection
1.3 Argatroban Segment by Application
1.3.1 Global Argatroban Sales Comparison by Application (2020-2026)
1.3.2 Heparin-induced thrombocytopenia (HIT)
1.3.3 Percutaneous Coronary Intervention
1.3.4 Cerebral arterial thrombosis
1.4 Argatroban Market Estimates and Forecasts (2015-2026)
1.4.1 Global Argatroban Sales Growth Rate (2015-2026)
1.4.2 Global Argatroban Revenue and Growth Rate (2015-2026)
1.4.3 Global Argatroban Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Argatroban Industry Impact
1.5.1 How the Covid-19 is Affecting the Argatroban Industry
1.5.1.1 Argatroban Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Argatroban Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Argatroban Players to Combat Covid-19 Impact
2 Argatroban Estimate and Forecast by Region
2.1 Global Argatroban Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Argatroban Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Argatroban Sales Market Share by Region (2015-2020)
2.2.2 Global Argatroban Revenue Market Share by Region (2015-2020)
2.3 Global Argatroban Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Argatroban Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Argatroban Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Argatroban Estimates and Projections (2015-2026)
2.4.2 Europe Argatroban Estimates and Projections (2015-2026)
2.4.3 China Argatroban Estimates and Projections (2015-2026)
2.4.4 Japan Argatroban Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Argatroban Estimates and Projections (2015-2026)
2.4.6 India Argatroban Estimates and Projections (2015-2026)
3 Global Argatroban Competition Landscape by Players
3.1 Global Top Argatroban Players by Sales (2015-2020)
3.2 Global Top Argatroban Players by Revenue (2015-2020)
3.3 Global Argatroban Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Argatroban as of 2019)
3.4 Global Argatroban Average Price by Company (2015-2020)
3.5 Manufacturers Argatroban Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Argatroban Players (Opinion Leaders)
4 Global Argatroban Market Size by Type
4.1 Global Argatroban Historic Market Review by Type (2015-2020)
4.1.1 Global Argatroban Sales Market Share by Type (2015-2020)
4.1.2 Global Argatroban Revenue Market Share by Type (2015-2020)
4.1.3 Global Argatroban Price by Type (2014-2020)
4.2 Global Argatroban Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Argatroban Sales Forecast by Type (2021-2026)
4.2.2 Global Argatroban Revenue Forecast by Type (2021-2026)
4.2.3 Global Argatroban Price Forecast by Type (2021-2026)
5 Global Argatroban Market Size by Application
5.1 Global Argatroban Historic Market Review by Application (2015-2020)
5.1.1 Global Argatroban Sales Market Share by Application (2015-2020)
5.1.2 Global Argatroban Revenue Market Share by Application (2015-2020)
5.1.3 Global Argatroban Price by Application (2015-2020)
5.2 Global Argatroban Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Argatroban Sales Forecast by Application (2021-2026)
5.2.2 Global Argatroban Revenue Forecast by Application (2021-2026)
5.2.3 Global Argatroban Price Forecast by Application (2021-2026)
3 North America Argatroban Market Facts & Figures
3.2 North America Argatroban Sales Market Share by Company (2015-2020)
3.3 North America Argatroban Sales Market Share by Type (2015-2020)
3.4 North America Argatroban Sales Market Share by Application (2015-2020)
4 Europe Argatroban Market Facts & Figures
4.2 Europe Argatroban Sales Market Share by Company (2015-2020)
4.3 Europe Argatroban Sales Market Share by Type (2015-2020)
4.4 Europe Argatroban Sales Market Share by Application (2015-2020)
5 China Argatroban Market Facts & Figures
5.2 China Argatroban Sales Market Share by Company (2015-2020)
5.3 China Argatroban Sales Market Share by Type (2015-2020)
5.4 China Argatroban Sales Market Share by Application (2015-2020)
6 Japan Argatroban Market Facts & Figures
6.2 Japan Argatroban Sales Market Share by Company (2015-2020)
6.3 Japan Argatroban Sales Market Share by Type (2015-2020)
6.4 Japan Argatroban Sales Market Share by Application (2015-2020)
7 Southeast Asia Argatroban Market Facts & Figures
7.2 Southeast Asia Argatroban Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Argatroban Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Argatroban Sales Market Share by Application (2015-2020)
8 India Argatroban Market Facts & Figures
8.2 India Argatroban Sales Market Share by Company (2015-2020)
8.3 India Argatroban Sales Market Share by Type (2015-2020)
8.4 India Argatroban Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Argatroban Business
12.1 Pfizer, Inc
12.1.1 Pfizer, Inc Argatroban Corporation Information
12.1.2 Pfizer, Inc Argatroban Business Overview and Total Revenue
12.1.3 Pfizer, Inc Argatroban Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Pfizer, Inc Argatroban Products Offered
12.1.5 Pfizer, Inc Recent Development
12.2 SANDOZ
12.2.1 SANDOZ Argatroban Corporation Information
12.2.2 SANDOZ Argatroban Business Overview and Total Revenue
12.2.3 SANDOZ Argatroban Sales, Revenue and Gross Margin (2015-2020)
12.2.4 SANDOZ Argatroban Products Offered
12.2.5 SANDOZ Recent Development
12.3 GlaxoSmithKline Plc
12.3.1 GlaxoSmithKline Plc Argatroban Corporation Information
12.3.2 GlaxoSmithKline Plc Argatroban Business Overview and Total Revenue
12.3.3 GlaxoSmithKline Plc Argatroban Sales, Revenue and Gross Margin (2015-2020)
12.3.4 GlaxoSmithKline Plc Argatroban Products Offered
12.3.5 GlaxoSmithKline Plc Recent Development
12.4 fresenius-kabi
12.4.1 fresenius-kabi Argatroban Corporation Information
12.4.2 fresenius-kabi Argatroban Business Overview and Total Revenue
12.4.3 fresenius-kabi Argatroban Sales, Revenue and Gross Margin (2015-2020)
12.4.4 fresenius-kabi Argatroban Products Offered
12.4.5 fresenius-kabi Recent Development
12.5 Eagle Pharmaceuticals, Inc
12.5.1 Eagle Pharmaceuticals, Inc Argatroban Corporation Information
12.5.2 Eagle Pharmaceuticals, Inc Argatroban Business Overview and Total Revenue
12.5.3 Eagle Pharmaceuticals, Inc Argatroban Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Eagle Pharmaceuticals, Inc Argatroban Products Offered
12.5.5 Eagle Pharmaceuticals, Inc Recent Development
12.6 Mitsubishi Tanabe Pharma
12.6.1 Mitsubishi Tanabe Pharma Argatroban Corporation Information
12.6.2 Mitsubishi Tanabe Pharma Argatroban Business Overview and Total Revenue
12.6.3 Mitsubishi Tanabe Pharma Argatroban Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Mitsubishi Tanabe Pharma Argatroban Products Offered
12.6.5 Mitsubishi Tanabe Pharma Recent Development
12.7 Teva Pharmaceutical Industries Ltd
12.7.1 Teva Pharmaceutical Industries Ltd Argatroban Corporation Information
12.7.2 Teva Pharmaceutical Industries Ltd Argatroban Business Overview and Total Revenue
12.7.3 Teva Pharmaceutical Industries Ltd Argatroban Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Teva Pharmaceutical Industries Ltd Argatroban Products Offered
12.7.5 Teva Pharmaceutical Industries Ltd Recent Development
12.8 WEST-WARD,INC
12.8.1 WEST-WARD,INC Argatroban Corporation Information
12.8.2 WEST-WARD,INC Argatroban Business Overview and Total Revenue
12.8.3 WEST-WARD,INC Argatroban Sales, Revenue and Gross Margin (2015-2020)
12.8.4 WEST-WARD,INC Argatroban Products Offered
12.8.5 WEST-WARD,INC Recent Development
13 Argatroban Manufacturing Cost Analysis
13.1 Argatroban Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Argatroban
13.4 Argatroban Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Argatroban Distributors List
14.3 Argatroban Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Argatroban Sales (g) Growth Rate by Type (2020-2026)
Table 2. Global Argatroban Sales (g) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Argatroban Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Argatroban Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Argatroban Players to Combat Covid-19 Impact
Table 8. Global Market Argatroban Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Argatroban Sales (g) by Region (2015-2020)
Table 10. Global Argatroban Sales Market Share by Region (2015-2020)
Table 11. Global Argatroban Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Argatroban Revenue Share by Region (2015-2020)
Table 13. Global Argatroban Sales (g) Forecast by Region (2021-2026)
Table 14. Global Argatroban Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Argatroban Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Argatroban Revenue Share Forecast by Region (2021-2026)
Table 17. Global Argatroban (g) of Key Companies (2015-2020)
Table 18. Global Argatroban Sales Share by Company (2015-2020)
Table 19. Global Argatroban Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Argatroban Revenue Share by Company (2015-2020)
Table 21. Global Argatroban by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Argatroban as of 2019)
Table 22. Global Argatroban Average Price (USD/g) of Key Company (2015-2020)
Table 23. Manufacturers Argatroban Manufacturing Sites and Area Served
Table 24. Manufacturers Argatroban Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Argatroban Players
Table 27. Global Argatroban Sales (g) by Type (2015-2020)
Table 28. Global Argatroban Sales Share by Type (2015-2020)
Table 29. Global Argatroban Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Argatroban Price (g) by Type (2015-2020)
Table 31. Global Argatroban Sales Share by Type (2021-2026)
Table 32. Global Argatroban Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Argatroban Revenue Share by Type (2021-2026)
Table 34. Global Argatroban Price (g) by Type (2021-2026)
Table 35. Global Argatroban Sales (g) by Application (2015-2020)
Table 36. Global Argatroban Sales Share by Application (2015-2020)
Table 37. Global Argatroban Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Argatroban Price (g) by Application (2015-2020)
Table 39. Global Argatroban Sales (g) by Application (2021-2026)
Table 40. Global Argatroban Sales Share by Application (2021-2026)
Table 41. Global Argatroban Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Argatroban Revenue Share by Application (2021-2026)
Table 43. Global Argatroban Price (g) by Application (2021-2026)
Table 44. United States Argatroban Sales (g) by Company (2015-2020)
Table 45. United States Argatroban Sales Market Share by Company (2015-2020)
Table 46. United States Argatroban Sales (g) by Type (2015-2020)
Table 47. United States Argatroban Sales Market Share by Type (2015-2020)
Table 48. United States Argatroban Sales (g) by Application (2015-2020)
Table 49. United States Argatroban Sales Market Share by Application (2015-2020)
Table 50. Europe Argatroban Sales (g) by Company (2015-2020)
Table 51. Europe Argatroban Sales Market Share by Company (2015-2020)
Table 52. Europe Argatroban Sales (g) by Type (2015-2020)
Table 53. Europe Argatroban Sales Market Share by Type (2015-2020)
Table 54. Europe Argatroban Sales (g) by Application (2015-2020)
Table 55. Europe Argatroban Sales Market Share by Type (2015-2020)
Table 56. China Argatroban Sales (g) by Company (2015-2020)
Table 57. China Argatroban Sales Market Share by Company (2015-2020)
Table 58. China Argatroban Sales (g) by Type (2015-2020)
Table 59. China Argatroban Sales Market Share by Type (2015-2020)
Table 60. China Argatroban Sales (g) by Application (2015-2020)
Table 61. China Argatroban Sales Market Share by Application (2015-2020)
Table 62. Japan Argatroban Sales (g) by Company (2015-2020)
Table 63. Japan Argatroban Sales Market Share by Company (2015-2020)
Table 64. Japan Argatroban Sales (g) by Type (2015-2020)
Table 65. Japan Argatroban Sales Market Share by Type (2015-2020)
Table 66. Japan Argatroban Sales (g) by Application (2015-2020)
Table 67. Japan Argatroban Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Argatroban Sales (g) by Company (2015-2020)
Table 69. Southeast Asia Argatroban Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Argatroban Sales (g) by Type (2015-2020)
Table 71. Southeast Asia Argatroban Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Argatroban Sales (g) by Type (2015-2020)
Table 73. Southeast Asia Argatroban Sales Market Share by Application (2015-2020)
Table 74. India Argatroban Sales (g) by Company (2015-2020)
Table 75. India Argatroban Sales Market Share by Company (2015-2020)
Table 76. India Argatroban Sales (g) by Type (2015-2020)
Table 77. India Argatroban Sales Market Share by Type (2015-2020)
Table 78. India Argatroban Sales (g) by Application (2015-2020)
Table 79. India Argatroban Sales Market Share by Application (2015-2020)
Table 80. Pfizer, Inc Corporation Information
Table 81. Pfizer, Inc Description and Business Overview
Table 82. Pfizer, Inc Argatroban Sales (g), Revenue (Million USD), Price (USD/g) and Gross Margin (2015-2020)
Table 83. Pfizer, Inc Argatroban Product
Table 84. Pfizer, Inc Recent Development
Table 85. SANDOZ Corporation Information
Table 86. SANDOZ Description and Business Overview
Table 87. SANDOZ Argatroban Sales (g), Revenue (Million USD), Price (USD/g) and Gross Margin (2015-2020)
Table 88. SANDOZ Argatroban Product
Table 89. SANDOZ Recent Development
Table 90. GlaxoSmithKline Plc Corporation Information
Table 91. GlaxoSmithKline Plc Description and Business Overview
Table 92. GlaxoSmithKline Plc Argatroban Sales (g), Revenue (Million USD), Price (USD/g) and Gross Margin (2015-2020)
Table 93. GlaxoSmithKline Plc Argatroban Product
Table 94. GlaxoSmithKline Plc Recent Development
Table 95. fresenius-kabi Corporation Information
Table 96. fresenius-kabi Description and Business Overview
Table 97. fresenius-kabi Argatroban Sales (g), Revenue (Million USD), Price (USD/g) and Gross Margin (2015-2020)
Table 98. fresenius-kabi Argatroban Product
Table 99. fresenius-kabi Recent Development
Table 100. Eagle Pharmaceuticals, Inc Corporation Information
Table 101. Eagle Pharmaceuticals, Inc Description and Business Overview
Table 102. Eagle Pharmaceuticals, Inc Argatroban Sales (g), Revenue (Million USD), Price (USD/g) and Gross Margin (2015-2020)
Table 103. Eagle Pharmaceuticals, Inc Argatroban Product
Table 104. Eagle Pharmaceuticals, Inc Recent Development
Table 105. Mitsubishi Tanabe Pharma Corporation Information
Table 106. Mitsubishi Tanabe Pharma Description and Business Overview
Table 107. Mitsubishi Tanabe Pharma Argatroban Sales (g), Revenue (Million USD), Price (USD/g) and Gross Margin (2015-2020)
Table 108. Mitsubishi Tanabe Pharma Argatroban Product
Table 109. Mitsubishi Tanabe Pharma Recent Development
Table 110. Teva Pharmaceutical Industries Ltd Corporation Information
Table 111. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 112. Teva Pharmaceutical Industries Ltd Argatroban Sales (g), Revenue (Million USD), Price (USD/g) and Gross Margin (2015-2020)
Table 113. Teva Pharmaceutical Industries Ltd Argatroban Product
Table 114. Teva Pharmaceutical Industries Ltd Recent Development
Table . WEST-WARD,INC Corporation Information
Table . WEST-WARD,INC Argatroban Sales (g), Revenue (Million USD), Price (USD/g) and Gross Margin (2015-2020)
Table . WEST-WARD,INC Description and Business Overview
Table . WEST-WARD,INC Argatroban Product
Table . WEST-WARD,INC Recent Development
Table 120. Production Base and Market Concentration Rate of Raw Material
Table 121. Key Suppliers of Raw Materials
Table 122. Argatroban Distributors List
Table 123. Argatroban Customers List
Table 124. Market Key Trends
Table 125. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 126. Key Challenges
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Argatroban Product Picture
Figure 2. Global Argatroban Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Argatroban Market Share by Application in 2020 & 2026
Figure 6. Heparin-induced thrombocytopenia (HIT) Examples
Figure 7. Percutaneous Coronary Intervention Examples
Figure 8. Cerebral arterial thrombosis Examples
Figure 9. Global Argatroban Sales (g) Growth Rate (2015-2026)
Figure 10. Global Argatroban Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Argatroban Price Trends Growth Rate (2015-2026) (USD/g)
Figure 12. Global Argatroban Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Argatroban Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Argatroban Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Argatroban Sales (g) Growth Rate (2015-2026)
Figure 16. Europe Argatroban Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Argatroban Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Argatroban Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Argatroban Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Argatroban Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Argatroban Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Argatroban Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Argatroban Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Argatroban Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Argatroban Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Argatroban Players Market Share by Revenue in Argatroban 2015 & 2019
Figure 27. Argatroban Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Argatroban Revenue Share by Type (2015-2020)
Figure 29. Global Argatroban Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Argatroban Revenue Share by Application (2015-2020)
Figure 31. Global Argatroban Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Argatroban Sales Market Share by Type in 2019
Figure 33. United States Argatroban Sales Market Share by Type in 2019
Figure 34. Europe Argatroban Sales Market Share by Company in 2019
Figure 35. Europe Argatroban Sales Market Share by Type in 2019
Figure 36. Europe Argatroban Sales Market Share by Application in 2019
Figure 37. China Argatroban Sales Market Share by Company in 2019
Figure 38. China Argatroban Sales Market Share by Type in 2019
Figure 39. China Argatroban Sales Market Share by Application in 2019
Figure 40. Japan Argatroban Sales Market Share by Company in 2019
Figure 41. Japan Argatroban Sales Market Share by Type in 2019
Figure 42. Japan Argatroban Sales Market Share by Application in 2019
Figure 43. Southeast Asia Argatroban Sales Market Share by Company in 2019
Figure 44. Southeast Asia Argatroban Sales Market Share by Type in 2019
Figure 45. Southeast Asia Argatroban Sales Market Share by Application in 2019
Figure 46. India Argatroban Sales Market Share by Company in 2019
Figure 47. India Argatroban Sales Market Share by Type in 2019
Figure 48. India Argatroban Sales Market Share by Application in 2019
Figure 49. Pfizer, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. SANDOZ Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. GlaxoSmithKline Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. fresenius-kabi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Eagle Pharmaceuticals, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Mitsubishi Tanabe Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Teva Pharmaceutical Industries Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. WEST-WARD,INC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Key Raw Materials Price Trend
Figure 58. Manufacturing Cost Structure of Argatroban
Figure 59. Manufacturing Process Analysis of Argatroban
Figure 60. Argatroban Industrial Chain Analysis
Figure 61. Channels of Distribution
Figure 62. Distributors Profiles
Figure 63. Porter's Five Forces Analysis
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
複雑経皮的冠動脈インターベンションの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Complex Percutaneous Coronary Intervention market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Co…- 経皮的冠動脈形成術（PTCA）カテーテルの世界市場レポート2020 Percutaneous transluminal coronary angioplasty (PTCA) is a minimally invasive procedure to open up blocked coronary arteries, allowing blood to circulate unobstructed to the heart muscle. Market Analysis and Insights: Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters Market The …
- ヘパリンナトリウム注射の世界市場レポート2020 A recently published report by QY Research titled Global Heparin Sodium Injection Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides ac…
- 経皮経管冠動脈形成術（PTCA）カテーテルの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx mi…
- 経皮的冠動脈形成術（PTCA）バルーンカテーテルの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.3% in the forecast period of 2020 to 2025 and will expected to reach USD 1126.6 million by 2025, f…